Cefazolin

Bacterial Infections

Cefazolin is used to treat serious infections caused by susceptible bacteria in many different parts of the body. Common uses include:

• Respiratory tract infections: Such as pneumonia and other lung-related bacterial issues.
• Skin and skin structure infections: Including infections of the skin and the tissues just beneath it.
• Bone and joint infections: To treat bacterial growth within the skeletal system.
• Urinary tract infections: Including infections of the bladder and kidneys.
• Genital infections: Such as infections of the prostate or other reproductive organs.
• Biliary tract infections: Infections involving the gallbladder or bile ducts.
• Blood and heart infections: Including septicemia (blood poisoning) and endocarditis (infection of the heart valves or lining).

Surgical Use

Healthcare providers frequently use cefazolin for surgical prophylaxis. This involves administering the medication before, during, and sometimes shortly after a surgical procedure to reduce the risk of the patient developing a post-operative infection.

Limitations of Use

Cefazolin is only effective against infections caused by bacteria. It does not work for viral infections, such as the common cold or the flu. Using an antibiotic when it is not needed can lead to antibiotic resistance, which may make the drug less effective for future infections.

How Cefazolin Fights Infection

Cefazolin belongs to a class of drugs known as cephalosporin antibiotics. It is specifically categorized as a first-generation cephalosporin. These medications work by targeting the structural integrity of bacteria.

The primary way cefazolin works is by:

• Inhibiting cell wall synthesis: Bacteria require a rigid outer cell wall to survive and protect themselves from their environment. Cefazolin prevents bacteria from properly building this wall.
• Weakening the bacteria: By disrupting the construction of the cell wall, the medication causes the bacteria to become unstable.
• Eliminating the infection: Once the cell wall is compromised, the bacteria typically rupture and die. This process stops the bacteria from multiplying and spreading throughout the body, allowing the immune system to clear the remaining infection.

Cefazolin is effective against a variety of bacteria, including both Gram-positive and some Gram-negative organisms. However, it is important to note that this medication only works against bacterial infections. It will not work for viral infections, such as the common cold or the flu.

Common Side Effects

Some people may experience mild side effects while receiving cefazolin. These often do not require immediate medical attention unless they persist or become bothersome:

• Pain, swelling, or redness at the site of injection
• Nausea or vomiting
• Mild diarrhea
• Loss of appetite
• Stomach pain or heartburn

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Signs of an allergic reaction, such as skin rash, itching, hives, or swelling of the face, lips, tongue, or throat
• Difficulty breathing or wheezing
• Severe stomach cramps and watery or bloody diarrhea, which may occur during treatment or up to several months after the last dose
• Fever, chills, or sore throat
• Unusual bruising or bleeding
• Seizures
• Yellowing of the skin or eyes (jaundice)
• Dark-colored urine or a significant change in the amount of urine produced

Allergic Reactions

Serious and occasionally fatal hypersensitivity reactions, including anaphylaxis, have been reported with cefazolin. Before starting treatment, it is important to determine if a patient has had previous reactions to cephalosporins, penicillins, or other drugs. There is a risk of cross-sensitivity among beta-lactam antibiotics, meaning individuals allergic to penicillin may also react to cefazolin.

Intestinal Complications

Nearly all antibacterial agents, including cefazolin, can cause Clostridioides difficile-associated diarrhea (CDAD). This condition occurs because the antibiotic changes the natural balance of bacteria in the colon, allowing C. difficile to grow. Symptoms can range from mild diarrhea to fatal colitis. This complication can occur more than two months after the antibiotic treatment has ended.

Neurological Risks and Seizures

Seizures may occur during treatment, particularly in patients with kidney impairment who receive high doses of the medication. If seizures occur, the medication is typically discontinued, and appropriate medical management is initiated.

Kidney Impairment

Because cefazolin is primarily cleared by the kidneys, the dosage must be reduced for patients with decreased kidney function. Failure to adjust the dose can lead to high levels of the drug in the blood and increase the risk of toxicity and seizures.

Blood Clotting and Other Concerns

• Prothrombin Time: Some patients may experience a decrease in prothrombin activity, which can affect blood clotting. Those at higher risk include individuals with kidney or liver impairment, poor nutritional status, or those receiving a long course of antibiotic therapy.
• Superinfection: Prolonged use of cefazolin may result in the overgrowth of non-susceptible organisms, such as fungi. If a new infection develops during treatment, appropriate measures must be taken.

Pregnancy

Cefazolin should be used during pregnancy only if a healthcare provider determines it is clearly needed. While animal reproduction studies have not shown evidence of harm to the fetus, there are no adequate and well-controlled studies in pregnant women. Because animal studies do not always predict human response, caution is recommended when using this medication during pregnancy.

If cefazolin is administered before a cesarean section, the drug crosses the placenta and can be detected in the cord blood and amniotic fluid.

Breastfeeding

Cefazolin passes into breast milk in low concentrations. It is generally considered compatible with breastfeeding, but it is important to discuss the risks and benefits with a healthcare provider. Nursing infants should be monitored for potential side effects, such as:

• Diarrhea or changes in bowel movements.
• Oral thrush (a yeast infection in the mouth).
• Allergic reactions or skin rashes.

Available Forms

Cefazolin is provided in the following forms for administration by a healthcare professional:

• Powder for Injection: Supplied in vials or pharmacy bulk packages for reconstitution and further dilution.
• Premixed Solution: Available in plastic containers as a frozen or ready-to-use solution for intravenous infusion.

This medication is administered either as an injection into a large muscle or as an infusion or injection into a vein.

FDA Approval and Indications

Cefazolin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of various serious infections caused by susceptible organisms. These include:

• Respiratory tract infections
• Urinary tract infections
• Skin and skin structure infections
• Biliary tract infections
• Bone and joint infections
• Genital infections
• Septicemia
• Endocarditis

It is also FDA-approved for perioperative prophylaxis, which involves administering the medication before, during, and after surgery to prevent the development of infections.

Regulatory Status

Cefazolin is available only by prescription. It does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program. The medication is typically administered in a clinical setting by healthcare professionals via intravenous or intramuscular injection.

Safety Communications and Recalls

The FDA monitors the safety and manufacturing of cefazolin. In the past, specific manufacturers have issued voluntary recalls due to quality control issues. For instance, a recall was previously issued for a specific lot of cefazolin due to mispackaging, where the product was placed in cartons intended for a different medication. Patients and healthcare providers are encouraged to report adverse effects or quality issues to the FDA MedWatch program.

Use During Pregnancy

Cefazolin is often used during pregnancy when a bacterial infection requires treatment. While comprehensive studies in pregnant women are limited, current evidence suggests the following:

• Animal Research: Studies in animals have not shown that cefazolin causes birth defects or fertility problems, even at doses much higher than those typically given to humans.
• Clinical Use: This medication is frequently used in clinical settings for pregnant patients, including as a preventive measure before a cesarean section to reduce the risk of infection.
• Consultation: It is important to discuss your pregnancy status with a healthcare provider. They will evaluate whether the medication is clearly needed to treat your specific condition.